BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32902893)

  • 21. Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion.
    Kim A; Han JY; Ryu CM; Yu HY; Lee S; Kim Y; Jeong SU; Cho YM; Shin DM; Choo MS
    Histopathology; 2017 Sep; 71(3):415-424. PubMed ID: 28394416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.
    Akiyama Y; Luo Y; Hanno PM; Maeda D; Homma Y
    Int J Urol; 2020 Jun; 27(6):491-503. PubMed ID: 32246572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment.
    Yu WR; Jhang JF; Ho HC; Jiang YH; Lee CL; Hsu YH; Kuo HC
    Sci Rep; 2021 Jan; 11(1):455. PubMed ID: 33432045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Difference in electron microscopic findings among interstitial cystitis/bladder pain syndrome with distinct clinical and cystoscopic characteristics.
    Lee YK; Jhang JF; Jiang YH; Hsu YH; Ho HC; Kuo HC
    Sci Rep; 2021 Aug; 11(1):17258. PubMed ID: 34446784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation.
    Maeda D; Akiyama Y; Morikawa T; Kunita A; Ota Y; Katoh H; Niimi A; Nomiya A; Ishikawa S; Goto A; Igawa Y; Fukayama M; Homma Y
    PLoS One; 2015; 10(11):e0143316. PubMed ID: 26587589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Features of Various Bladder Lesions and Their Impact on Clinical Symptoms and Recurrence in Interstitial Cystitis.
    Shin JH; Kang B; Choo MS
    J Urol; 2021 Sep; 206(3):669-678. PubMed ID: 33890486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in Urodynamic Parameters According to the Presence of a Hunner Lesion in Women With Interstitial Cystitis/Bladder Pain Syndrome.
    Ahn ST; Jeong HG; Park TY; Kim JW; Park HS; Moon DG; Lee JG; Oh MM
    Int Neurourol J; 2018 Jan; 22(Suppl 1):S55-61. PubMed ID: 29385787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cystoscopic and histological findings in patients with suspected interstitial cystitis.
    Denson MA; Griebling TL; Cohen MB; Kreder KJ
    J Urol; 2000 Dec; 164(6):1908-11. PubMed ID: 11061878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of cystoscopy and hydrodistention on symptoms and bladder capacity in interstitial cystitis/bladder pain syndrome.
    Kirk PS; Santiago-Lastra Y; Qin Y; Stoffel JT; Clemens JQ; Cameron AP
    Neurourol Urodyn; 2018 Aug; 37(6):2002-2007. PubMed ID: 29566264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells for Treating Interstitial Cystitis: A Phase I Study.
    Shin JH; Ryu CM; Yu HY; Park J; Kang AR; Shin JM; Hong KS; Kim EY; Chung HM; Shin DM; Choo MS
    Stem Cells Transl Med; 2022 Oct; 11(10):1010-1020. PubMed ID: 36069837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of Bladder Capacity Under Anesthesia Following Multiple Recurrences and Repeated Surgeries of Hunner Lesions in Patients With Interstitial Cystitis.
    Furuta A; Suzuki Y; Igarashi T; Kimura T; Egawa S; Yoshimura N
    Int Neurourol J; 2022 Mar; 26(1):45-51. PubMed ID: 35368185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
    Jhang JF; Hsu YH; Kuo HC
    Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supervised machine learning algorithm identified KRT20, BATF and TP63 as biologically relevant biomarkers for bladder biopsy specimens from interstitial cystitis/bladder pain syndrome patients.
    Kamasako T; Kaga K; Inoue KI; Hariyama M; Yamanishi T
    Int J Urol; 2022 May; 29(5):406-412. PubMed ID: 35102612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics differ considerably between phenotypes of bladder pain syndrome/interstitial cystitis.
    Logadottir Y; Fall M; Kåbjörn-Gustafsson C; Peeker R
    Scand J Urol Nephrol; 2012 Oct; 46(5):365-70. PubMed ID: 22607036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrodistension with or without fulguration of hunner lesions for interstitial cystitis: Long-term outcomes and prognostic predictors.
    Niimi A; Nomiya A; Yamada Y; Suzuki M; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    Neurourol Urodyn; 2016 Nov; 35(8):965-969. PubMed ID: 26208131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic and therapeutic efficacy of cystoscopy with hydrodistension and random biopsies in clinically suspected interstitial cystitis/bladder pain syndrome.
    Chen Y; Ying Z; Xiao Y; Liu Y; Wu S
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():156-161. PubMed ID: 34492610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report.
    Fall M; Nordling J; Cervigni M; Dinis Oliveira P; Fariello J; Hanno P; Kåbjörn-Gustafsson C; Logadottir Y; Meijlink J; Mishra N; Moldwin R; Nasta L; Quaghebeur J; Ratner V; Sairanen J; Taneja R; Tomoe H; Ueda T; Wennevik G; Whitmore K; Wyndaele JJ; Zaitcev A
    Scand J Urol; 2020 Apr; 54(2):91-98. PubMed ID: 32107957
    [No Abstract]   [Full Text] [Related]  

  • 38. Fulguration for Hunner ulcers: long-term clinical outcomes.
    Hillelsohn JH; Rais-Bahrami S; Friedlander JI; Okhunov Z; Kashan M; Rosen L; Moldwin RM
    J Urol; 2012 Dec; 188(6):2238-41. PubMed ID: 23083651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small Fiber Polyneuropathy in Hunner Lesion and Non-Hunner Lesion Interstitial Cystitis/Bladder Pain Syndrome.
    Han E; Killinger KA; Turner KM; Gilleran J; Tenney D; Peters KM
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e91-e95. PubMed ID: 32217920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
    Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
    Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.